Benjamin Edwards Inc Astrazeneca PLC Transaction History
Benjamin Edwards Inc
- $6.71 Billion
- Q3 2024
A detailed history of Benjamin Edwards Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Benjamin Edwards Inc holds 59,871 shares of AZN stock, worth $4.07 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
59,871
Previous 13,334
349.01%
Holding current value
$4.07 Million
Previous $1.04 Million
348.56%
% of portfolio
0.07%
Previous 0.2%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.28 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.86 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.53 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.51 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.3 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...